Supporting Innovation and Entrepreneurship for more than 60 years

Welcome to Safeguard Scientifics' Blog, where we share Perspective, Strategy and Insight.

Archive: Medivo

Life Sciences

Week in Review: JOBS Act Update and Inc. 500|5000

Safeguard Scientifics’ CFO Steve Zarrilli covered the JOBS act as a win for startups, venture capital, and the economy. Since then, the law was passed by Congress and changes in funding and the IPO process are becoming evident. An important part of the new law was the encouragement of capital formation through “crowdfunding.” While the SEC is still writing the rules for…

Read more

Week in Review

Week in Review: Olympics Go Mobile and Social

Today, the Summer Olympic Games open in London, kicking off 16 days of athletic performance that will reveal the best in the world in 32 disciplines. But perhaps the most compelling achievement at the games will be the innovations in mobile broadcasting and social media that will make the 2012 Olympics more accessible and collaborative than any other Olympic Games.…

Read more

Week in Review

Week in Review: Enterprise 3.0, Social Media, Internet of Things, Mobile and Big Data

This week saw a number of conferences and announcements that underscore the continuing influence of the five technologies driving enterprise 3.0. Here are some of the highlights: Social Media: Facebook debuted real-time bidding for ads in a service called Facebook Exchange. This approach will deliver ads to users based on their Internet browsing patterns. Internet of Things: This week’s Connected…

Read more

Life Sciences

Week in Review: Facebook and Other Venture-Backed IPOs Grab Headlines

The big news today is the Facebook IPO. The company that famously started in a Harvard dorm room set three records at IPO, including the largest valuation for a venture-backed IPO, the most capital raised, and the most active acquirer pre-IPO. All this attention has also brought Facebook a number of detractors, some of whom warn of potential advertising concerns…

Read more

Investor Relations

RECAP: Safeguard Scientifics First Quarter 2012 Financial Results

Here is a recap of our first quarter 2012 financial results. Our team is executing a focused and disciplined strategy that enhances Safeguard’s brand as the preferred catalyst to build great companies. Our partner companies continue to generate attractive growth. In the first quarter, aggregate revenue of our partner companies grew 26 percent. For full-year 2012, we project aggregate partner…

Read more